Kevin G. Chen

4.2k total citations
67 papers, 3.2k citations indexed

About

Kevin G. Chen is a scholar working on Molecular Biology, Oncology and Biomedical Engineering. According to data from OpenAlex, Kevin G. Chen has authored 67 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 31 papers in Oncology and 9 papers in Biomedical Engineering. Recurrent topics in Kevin G. Chen's work include Drug Transport and Resistance Mechanisms (23 papers), Pluripotent Stem Cells Research (12 papers) and CRISPR and Genetic Engineering (11 papers). Kevin G. Chen is often cited by papers focused on Drug Transport and Resistance Mechanisms (23 papers), Pluripotent Stem Cells Research (12 papers) and CRISPR and Genetic Engineering (11 papers). Kevin G. Chen collaborates with scholars based in United States, China and France. Kevin G. Chen's co-authors include Branimir I. Šikić, Ronald D.G. McKay, Barbara S. Mallon, Pamela Gehron Robey, George E. Durán, Michael M. Gottesman, Kyeyoon Park, Vincent J. Hearing, Julio C. Valencia and Dolly B. Tyan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Kevin G. Chen

65 papers receiving 3.2k citations

Peers

Countries citing papers authored by Kevin G. Chen

Since Specialization

Citations

This map shows the geographic impact of Kevin G. Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin G. Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin G. Chen more than expected).

Fields of papers citing papers by Kevin G. Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin G. Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin G. Chen. The network helps show where Kevin G. Chen may publish in the future.

Co-authorship network of co-authors of Kevin G. Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin G. Chen. A scholar is included among the top collaborators of Kevin G. Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin G. Chen. Kevin G. Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genomic stability at the coding regions of the multidrug transporter gene ABCB1: insights into the development of alternative drug resistance mechanisms in human leukemia cells 2020 ·Cancer Drug Resistance ·Kevin G. Chen, George E. Durán, (unknown), (unknown), (unknown), Jean‐Pierre Jaffrézou, Lyn M. Huff, Kory Johnson, Tito Fojo, Norman J. Lacayo, Branimir I. Šikić	1
2	Advancing precision medicine with personalized drug screening 2018 ·Drug Discovery Today ·Kirill Gorshkov, Catherine Z. Chen, (unknown), Nino Mihatov, Yong‐Soo Choi, Ðắc-Trung Nguyễn, Noel Southall, Kevin G. Chen, John K. Park, Wei Zheng	31
3	Targeted inhibitors of P-glycoprotein increase chemotherapeutic-induced mortality of multidrug resistant tumor cells 2018 ·Scientific Reports ·Amila K. Nanayakkara, Courtney A. Follit, Kevin G. Chen, Noelle S. Williams, Pia D. Vogel, John G. Wise	224
4	Pluripotent Stem Cell Platforms for Drug Discovery 2018 ·Trends in Molecular Medicine ·Kevin G. Chen, Barbara S. Mallon, Kyeyoon Park, Pamela Gehron Robey, Ronald D.G. McKay, Michael M. Gottesman, Wei Zheng	33
5	Evaluation of genetic susceptibility of common variants in CACNA1D with schizophrenia in Han Chinese 2015 ·Scientific Reports ·Fanglin Guan, Lu Li, (unknown), Kevin G. Chen, Tinglin Yan, Tao Li, Tianxiao Zhang, Xinshe Liu	39
6	Variations in Glycogen Synthesis in Human Pluripotent Stem Cells with Altered Pluripotent States 2015 ·PLoS ONE ·Richard J. Chen, Guofeng Zhang, Susan H. Garfield, Yijun Shi, Kevin G. Chen, Pamela Gehron Robey, Richard D. Leapman	15
7	Developmental insights from early mammalian embryos and core signaling pathways that influence human pluripotent cell growth and differentiation 2014 ·Stem Cell Research ·Kevin G. Chen, Barbara S. Mallon, Kory R. Johnson, Rebecca S. Hamilton, Ronald D.G. McKay, Pamela Gehron Robey	23
8	Human Pluripotent Stem Cell Culture: Considerations for Maintenance, Expansion, and Therapeutics 2014 ·Cell stem cell ·Kevin G. Chen, Barbara S. Mallon, Ronald D.G. McKay, Pamela Gehron Robey	268
9	Alternative Cultures for Human Pluripotent Stem Cell Production, Maintenance, and Genetic Analysis 2014 ·Journal of Visualized Experiments ·Kevin G. Chen, Rebecca S. Hamilton, Pamela Gehron Robey, Barbara S. Mallon	6
10	Non-colony type monolayer culture of human embryonic stem cells 2012 ·Stem Cell Research ·Kevin G. Chen, Barbara S. Mallon, Rebecca S. Hamilton, (unknown), Kyeyoon Park, Daniel J. Hoeppner, Pamela Gehron Robey, Ronald D.G. McKay	34
11	Heat shock proteins and p53 play a critical role in K+ channel-mediated tumor cell proliferation and apoptosis 2007 ·APOPTOSIS ·Xiaobing Han, Fang Wang, (unknown), Hui Xing, Danhui Weng, Xiaohong Song, Kevin G. Chen, Ling Xi, Tao Zhu, Jianfeng Zhou, Gang Xu, Shixuan Wang, Meng Li, Costantino Iadecola, Gang Wang, Ding Ma	40
12	Melanosomal sequestration of cytotoxic drugs contributes to the intractability of malignant melanomas 2006 ·Proceedings of the National Academy of Sciences ·Kevin G. Chen, Julio C. Valencia, Barry Lai, Guofeng Zhang, (unknown), François Rouzaud, Werner Berens, Stephen Wincovitch, Susan H. Garfield, Richard D. Leapman, Vincent J. Hearing, Michael M. Gottesman	141
13	Toward xeno-free culture of human embryonic stem cells 2006 ·The International Journal of Biochemistry & Cell Biology ·Barbara S. Mallon, Kyeyoon Park, Kevin G. Chen, Rebecca S. Hamilton, Ronald D.G. McKay	136
14	Genetic and Epigenetic Modeling of the Origins of Multidrug-Resistant Cells in a Human Sarcoma Cell Line 2005 ·Cancer Research ·Kevin G. Chen, Yan C. Wang, Marci E. Schaner, Brian San Francisco, George E. Durán, Dejan Juric, Lyn M. Huff, Hesed Padilla‐Nash, Thomas Ried, Tito Fojo, Branimir I. Šikić	41
15	Quantitative trait locus analysis of nonverbal communication in autism spectrum disorder 2005 ·Molecular Psychiatry ·Kevin G. Chen, Naoko Kono, Daniel H. Geschwind, Rita M. Cantor	44
16	Preferential expression of a mutant allele of the amplified MDR1 (ABCB1) gene in drug‐resistant variants of a human sarcoma 2002 ·Genes Chromosomes and Cancer ·Kevin G. Chen, Norman J. Lacayo, George E. Durán, (unknown), Charles D. Bangs, Susan Rea, Mary S. Kovacs, Athena M. Cherry, J. Martin Brown, Branimir I. Šikić	20
17	Multidrug-resistant Human Sarcoma Cells with a Mutant P-Glycoprotein, Altered Phenotype, and Resistance to Cyclosporins 1997 ·Journal of Biological Chemistry ·Kevin G. Chen, George E. Durán, (unknown), Norman J. Lacayo, Jean‐Pierre Jaffrézou, Charles Dumontet, Branimir I. Šikić	72
18	Decreased Mutation Rate for Cellular Resistance to Doxorubicin and Suppression of mdrl Gene Activation by the Cyclosporin PSC 833 1995 ·JNCI Journal of the National Cancer Institute ·Lidija Beketić-Orešković, George E. Durán, Kevin G. Chen, Charles Dumontet, Branimir I. Šikić	64
19	Inhibition of lysosomal acid sphingomyelinase by agents which reverse multidrug resistance 1995 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Jean‐Pierre Jaffrézou, Kevin G. Chen, George E. Durán, Catherine Müller, Christine Bordier, Guy Laurent, Branimir I. Šikić, Thierry Levade	52
20	Mutation Rates and Mechanisms of Resistance to Etoposide Determined From Flucattion Analysis 1994 ·JNCI Journal of the National Cancer Institute ·J P Jaffrézou, Kevin G. Chen, George E. Durán, J. Kühl, Branimir I. Šikić	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact